These findings demonstrate that PIK3C2B promotes a hypermetabolic state by coordinately enhancing mitochondrial oxidative capacity, glycolytic reserve, and expression of critical metabolic enzymes, thereby increasing bioenergetic adaptability in lung cancer cells. This evidence concerns the gene PIK3C2B and lung cancer.